Heterogeneous delivery across the blood-brain barrier limits the efficacy of an EGFR-targeting antibody drug conjugate in glioblastomaBianca M. Marin, Jann N. Sarkaria, Kendra A. Porath et al.|Neuro-Oncology|2021Cited by 81
Brain Distribution of a Panel of Epidermal Growth Factor Receptor Inhibitors Using Cassette Dosing in Wild-Type and Abcb1/Abcg2-Deficient MiceMinjee Kim, William F. Elmquist, Janice K. Laramy et al.|Drug Metabolism and Disposition|2019Cited by 49
Activation of STAT3 through combined SRC and EGFR signaling drives resistance to a mitotic kinesin inhibitor in glioblastomaRajappa S. Kenchappa, Steven S. Rosenfeld, Athanassios Dovas et al.|Cell Reports|2022Cited by 31